From LEX Dec 14, 2012

Bausch & Lomb – profit focus

Warburg Pincus’s audacity and opportunism is rewarded

Elderly people work out with wooden dumb-bells ©Getty From GLOBAL ECONOMY Dec 13, 2012

Infections drop down list of big killers

Chronic conditions led by heart disease and stroke top global league

From WORLD Dec 12, 2012

Roche pressed to refund UK

MPs call for an inquiry into wasteful health spending

Dec 12, 2012

Merck warns over drugs price cut as fiscal fix

Chief says ability to find new treatments will be curbed

From WORLD Dec 11, 2012

Europe votes for single patents system

Brussels ruling ends 40-year diplomatic odyssey

From TECHNOLOGY Dec 11, 2012

Social media a healthcare data gold mine

Fragmented and incomplete information sets up barriers

From LEX Dec 11, 2012

European patents – reinvention

A boost for Europe’s dismal research record

Dec 10, 2012

Amgen to acquire genetics pioneer Decode

US biotech group to pay $415m for the Icelandic company

From LEX Dec 10, 2012

Sanofi – pick-me-up

All that has changed for the group is its patent expiries are now in the past

Kevin Sharer ©Bryce Vickmark The Monday Interview from MANAGEMENT Dec 9, 2012

Lessons from corporate America

Kevin Sharer, outgoing head of Amgen, explains how the group taught him to be patient

From TECHNOLOGY Dec 8, 2012

Intrexon bids for the rest of Aqua Bounty

US biotechnology group acquired 47.5% in November

From PERSONAL FINANCE Dec 7, 2012

It’s not just about the money

Veteran corporate raider Jim Slater retains a taste for buccaneering capitalism

Dec 6, 2012

Court of Justice upholds AstraZeneca fine

Pharmaceutical group penalised for delaying generic competition

Dec 5, 2012

Drugs groups aim to halve cost of trials

Move comes as sales of new medicines slows

Lex Dec 4, 2012

Baxter / Gambro – no adrenalin rush

The deal is a reflection of the new normal that large corporations and even equity investors face

Dec 4, 2012

Patent expiries trigger pain drugs battle

Generic drug companies want to sell copies of narcotic painkillers

Dec 2, 2012

Cost of developing drugs jumps tenfold

Study stresses regulatory hurdles and return on capital demands

Dec 2, 2012

Allergan obesity business attracts buyers

The company produces Lap Band gastric devices, which constrict the stomach to reduce appetite

From INDUSTRIALS Dec 2, 2012

Tax threat prompts US dealmaking flurry

Companies rush to close deals as fiscal cliff deadline looms

From INDUSTRIALS Dec 1, 2012

SThree to consolidate existing locations

White-collar recruiter is to slow its expansion into emerging markets

Multimedia

FT data

Prime Minister David Cameron, Health Secretary Andrew Lansley and Deputy Prime Minister Nick Clegg meets nurses and doctors at Guys Hospital in London, where they earlier spoke on the changes to the Government's NHS reforms. The NHS wastes millions on unnecessarily expensive prescription drugs, says a new study

More stories

Energy

Financials

Industrials

Telecoms

Technology

Markets

Offers
FINANCIAL TIMES JOBSGlobal executive jobs Register today for free job alerts

COMPANIES VIDEOS

COMPANIES NEWS ON TWITTER

More FT Twitter accounts

EDITOR’S CHOICE

lunch with the ft

Illustration by Patrick Morgan of Ratan Tata ©Patrick Morgan Ratan Tata on how his job became a ‘personal issue’

ft magazine

Tim Harford JPMorgan’s auction: going, going, wrong

IN DEPTH

  1. Apple
  2. Libor investigation
  3. Mergers and acquisitions
  4. The New Wall Street
  5. BAE-EADS talks
More in depth

MOST POPULAR IN COMPANIES

  1. UBS faces $1bn fine over Libor allegations
  2. Google releases map app for iPhone
  3. Cheating banker jailed for insider trading
  4. Man Group faces heavy GLG write-off
  5. Counter-terrorism tools used to spot fraud

Latest headlines from CNBC

FINANCIAL TIMES JOBS

Enter job search
Register for free to receive the latest executive jobs by email

TOOLS & SERVICES

Multimedia

Tools

Updates

Quick links

Services